Hepatitis B vaccine and dialysis: current issues

被引:18
作者
Fabrizi, F
Martin, P
机构
[1] IRCCS, Maggiore Hosp, Nephrol & Dialysis Div, Milan, Italy
[2] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Liver Transplant Program, Los Angeles, CA USA
关键词
D O I
10.1177/039139880102401003
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
[No abstract available]
引用
收藏
页码:683 / 694
页数:12
相关论文
共 96 条
[1]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[2]  
*AM COLL PHYS, 1990, GUID ADULT IMM
[3]   Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients [J].
Anandh, U ;
Bastani, B ;
Ballal, S .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (01) :53-56
[4]  
[Anonymous], 1991, MMWR Recomm Rep, V40, P1
[5]   Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients [J].
Ayli, MD ;
Ensari, C ;
Ayli, M ;
Mandiroglu, F ;
Mut, S .
NEPHRON, 2000, 84 (03) :291-292
[6]  
BEASLEY RP, 1981, LANCET, V2, P1129
[7]  
BENHAMOU E, 1984, CLIN NEPHROL, V21, P143
[8]  
BOMMER J, 1985, P EUR DIAL TRANS, V21, P300
[9]  
BOMMER J, 1983, P EDTA, V30, P161
[10]  
BRODERSEN HP, 1995, NEPHROL DIAL TRANSPL, V10, P1780